These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8310978)

  • 41. Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
    Mahmud A; Feely J
    Hypertension; 2007 Feb; 49(2):272-5. PubMed ID: 17178976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the effects of amlodipine and captopril on clinic and ambulatory blood pressure.
    Lacourcière Y; Poirier L; Provencher P
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S25-8. PubMed ID: 1293305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
    Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W;
    Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A double-blind, parallel, comparative evaluation of amlodipine against captopril in the monotherapeutic treatment of mild and moderate essential hypertension: interim results.
    Velasco M; Hernández R; Urbina A; Hernández O; Guevara J
    Postgrad Med J; 1991; 67 Suppl 5():S32-4. PubMed ID: 1839436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of amlodipine on ambulatory blood pressure in hypertensive patients.
    Burris JF; Allenby KS; Mroczek WJ
    Am J Cardiol; 1994 Jan; 73(3):39A-43A. PubMed ID: 8310975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Open evaluation of amlodipine in the monotherapeutic treatment of systolic hypertension in the elderly.
    Vandewoude MF; Lambert M; Vryens R
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S28-9. PubMed ID: 16296704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Once-daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S72-5. PubMed ID: 2467134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.
    Glasser SP; Chrysant SG; Graves J; Rofman B; Koehn DK
    Am J Hypertens; 1989 Mar; 2(3 Pt 1):154-7. PubMed ID: 2522008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose captopril therapy in mild and moderate hypertension. Randomized comparison of twice daily vs three times daily doses.
    Corea L; Bentivoglio M; Verdecchia P
    Hypertension; 1983; 5(5 Pt 2):III157-9. PubMed ID: 6354933
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 24-hour blood pressure control with the once-daily calcium antagonist amlodipine.
    Raftery EB; Heber ME; Brigden G; Al-Khawaja I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S8-12. PubMed ID: 16296698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
    Chazova IE; Martynyuk TV
    Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily.
    Fujiwara T; Ii Y; Hatsuzawa J; Murase H; Watanabe T; Murakami M; Kimura N; Buch J; Tsuchihashi T; Saruta T
    J Hum Hypertens; 2009 Aug; 23(8):521-9. PubMed ID: 19148107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension.
    Park S; Chung N; Kwon J; Yoon JH; Kim YJ; Han DS; Kim HS
    Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Once vs twice daily administration of a fixed combination of captopril plus hydrochlorothiazide in essential hypertension: a double-blind crossover study in known responders to a standard combination.
    Lacourcière Y; Poirier L; Provencher P; Guivarc'h PH
    Br J Clin Pharmacol; 1991 Jul; 32(1):115-9. PubMed ID: 1888630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amlodipine in mild and moderate hypertension: initial Indian experience.
    Khokhani RC; Chopra P; Karnik ND; Bajan KD; Ailiani R; Waknis SS; Joseph TA; Chawla KP
    J Assoc Physicians India; 1993 Oct; 41(10):662-3. PubMed ID: 8294330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amlodipine with enalapril therapy in moderate-severe essential hypertension.
    Jensen H; Garsdal P; Davies J
    J Hum Hypertens; 1990 Oct; 4(5):541-5. PubMed ID: 2149389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension.
    Grimm RH; Black H; Rowen R; Lewin A; Shi H; Ghadanfar M;
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):31-6. PubMed ID: 11824857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia.
    Lee HY; Kim SY; Choi KJ; Yoo BS; Cha DH; Jung HO; Ryu DR; Choi JH; Lee KJ; Park TH; Oh JH; Kim SM; Choi JY; Kim KH; Shim J; Kim WS; Choi SW; Park DG; Song PS; Hong TJ; Rhee MY; Rha SW; Park SW
    Clin Ther; 2017 Dec; 39(12):2366-2379. PubMed ID: 29150250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension.
    Webster J; Fowler G; Jeffers TA; Lyons D; Witte K; Crichton WA; Wickham EA; Sanghera SS; Cornish R; Petrie JC
    Br J Clin Pharmacol; 1993 May; 35(5):499-505. PubMed ID: 8512762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.